Dian Diagnostics Group (300244) Stock Overview

Dian Diagnostics Group Co.,Ltd. operates as a third-party independent medical diagnostic service company in China. It offers medical diagnosis solutions for various general hospitals and specialty hospitals, community health service centers, township health centers, physical examination centers, disease prevention and control centers, and other medical and health institutions. It also engages in the research, development, and production of in vitro diagnostic reagents and related equipment. In addition, the company offers laboratory supplies and kits; AI-assisted digital pathology diagnosis solutions; multi-omics platform services; DP-TOF nucleic acid mass spectrometry solutions; and forensic drug testing products. Further, it provides supply chain optimization, information management, cold chain logistics, intelligent warehousing, sample library management, scientific research services, etc., as well as solutions for laboratory quality. The company was formerly known as Zhejiang DIAN Diagnostics Co., Ltd. and changed its name to Dian Diagnostics Group Co.,Ltd. in November 2017. Dian Diagnostics Group Co.,Ltd. was founded in 1996 and is based in Hangzhou, China.